3 October 2018

#KCR_QoM: Question of the Month – September Results

In September we asked our visitors for their opinion regarding the value of clinical consulting for their clinical research. A clear majority of our respondents (50%) replied they believe improved patient recruitment is the best value they see in scientific consulting. In second place (30%) our respondents chose protocol design to improve efficiencies and lastly, with 20%, our respondents declared that the best value from consulting services is an improved regulatory strategy.

The answers to #KCR_QoM in September are in line with what we wrote in early August about scientific consulting, and reflect the landscape of clinical research in today’s world. With a substantial amount of research being done on rare indications (some of them with a very low prevalence and incidence), experience in reaching those patients is of immense value for the companies pursuing said research and can even become a competitive advantage in the long run.

In any case, it is evident by the level of engagement of our visitors that scientific consulting services in clinical trial execution provide valuable experience and information for clinical research.

Stay tuned for the #KCR_QoM in October!


Results #KCR_QoM from previous months:

July 2018 - Where do you see the most growth potential for patient recruitment in the next 5 years?

June 2018 - What is the future of pharma/CRO industry events?

May 2018 - What is the future of the Functional Service Provision (FSP) business?

April 2018 - What technology will have the biggest impact on clinical trials execution in the next 3 years?

March 2018 - Consolidation in the CRO industry makes my work...


Media Contact

Joanna Lewandowska
Associate Director, PR & Marketing
mobile: (+48) 605 053 164